Aurora Cannabis Inc. (ACB.TO)
CAD 5.88
(-0.84%)
CAD 5.88
(-0.84%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 47.57 Million CAD | 31.55% |
| 2022 | 36.16 Million CAD | -84.71% |
| 2021 | 236.48 Million CAD | -34.06% |
| 2020 | 358.61 Million CAD | -5.29% |
| 2019 | 378.62 Million CAD | -4.18% |
| 2018 | 395.15 Million CAD | 96.83% |
| 2017 | 200.76 Million CAD | 214.58% |
| 2016 | 63.81 Million CAD | 1337.63% |
| 2015 | 4.43 Million CAD | 93.68% |
| 2014 | 2.29 Million CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q1 | 79.96 Million CAD | 3.94% |
| 2023 Q2 | 78.36 Million CAD | -2.0% |
| 2023 Q3 | 47.57 Million CAD | -39.29% |
| 2023 FY | 47.57 Million CAD | 31.55% |
| 2022 Q4 | 76.93 Million CAD | -3.8% |
| 2022 Q2 | 194.7 Million CAD | -31.94% |
| 2022 FY | 36.16 Million CAD | -84.71% |
| 2022 Q3 | 79.96 Million CAD | -58.93% |
| 2022 Q1 | 286.06 Million CAD | 20.96% |
| 2021 Q2 | 369.85 Million CAD | 1.82% |
| 2021 Q1 | 363.24 Million CAD | 1.29% |
| 2021 FY | 236.48 Million CAD | -34.06% |
| 2021 Q4 | 236.48 Million CAD | -31.16% |
| 2021 Q3 | 343.55 Million CAD | -7.11% |
| 2020 Q2 | 418.75 Million CAD | 13.22% |
| 2020 FY | 358.61 Million CAD | -5.29% |
| 2020 Q4 | 358.61 Million CAD | -12.05% |
| 2020 Q3 | 407.72 Million CAD | -2.63% |
| 2020 Q1 | 369.85 Million CAD | -2.32% |
| 2019 FY | 378.62 Million CAD | -4.18% |
| 2019 Q2 | 544.43 Million CAD | 4.47% |
| 2019 Q1 | 521.13 Million CAD | 31.88% |
| 2019 Q3 | 539.05 Million CAD | -0.99% |
| 2019 Q4 | 378.62 Million CAD | -29.76% |
| 2018 Q3 | 418.34 Million CAD | 23.41% |
| 2018 Q1 | 289.9 Million CAD | 44.4% |
| 2018 FY | 395.15 Million CAD | 96.83% |
| 2018 Q2 | 338.99 Million CAD | 16.93% |
| 2018 Q4 | 395.15 Million CAD | -5.54% |
| 2017 Q4 | 200.76 Million CAD | -2.83% |
| 2017 FY | 200.76 Million CAD | 214.58% |
| 2017 Q3 | 206.61 Million CAD | 84577.46% |
| 2017 Q2 | 244 Thousand CAD | -99.63% |
| 2017 Q1 | 66.84 Million CAD | 4.74% |
| 2016 Q4 | 63.81 Million CAD | 240.87% |
| 2016 Q1 | 11.85 Million CAD | 167.09% |
| 2016 Q2 | 18.94 Million CAD | 59.75% |
| 2016 Q3 | 18.72 Million CAD | -1.16% |
| 2016 FY | 63.81 Million CAD | 1337.63% |
| 2015 Q2 | 3 Million CAD | 0.0% |
| 2015 Q1 | 3 Million CAD | 30.89% |
| 2015 FY | 4.43 Million CAD | 93.68% |
| 2015 Q4 | 4.43 Million CAD | 10.98% |
| 2015 Q3 | 4 Million CAD | 33.33% |
| 2014 Q2 | 764.46 Thousand CAD | 2.51% |
| 2014 FY | 2.29 Million CAD | 0.0% |
| 2014 Q4 | 2.29 Million CAD | 189.38% |
| 2014 Q3 | 792.04 Thousand CAD | 3.61% |
| 2014 Q1 | 745.76 Thousand CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Avicanna Inc. | 95.36 Thousand CAD | -49787.796% |
| Avant Brands Inc. | 1.74 Million CAD | -2632.567% |
| Cardiol Therapeutics Inc. | 158.53 Thousand CAD | -29909.083% |
| Crescita Therapeutics Inc. | 815 Thousand CAD | -5737.301% |
| Knight Therapeutics Inc. | 44.01 Million CAD | -8.083% |
| MediPharm Labs Corp. | 69 Thousand CAD | -68847.826% |
| OrganiGram Holdings Inc. | 79 Thousand CAD | -60120.253% |
| Canopy Growth Corporation | 493.29 Million CAD | 90.356% |
| Willow Biosciences Inc. | 594 Thousand CAD | -7909.091% |
| Auxly Cannabis Group Inc. | 81.38 Million CAD | 41.543% |